Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Choline salicylate+glycerol 20%/12.6% ear drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Choline salicylate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing choline salicylate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Choline salicylate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Choline salicylate 870mg/5ml liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Choline salicylate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely choline salicylate 87 milligram/1 gram conventional release oral gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Choline salicylate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing choline salicylate and glycerol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Choline salicylate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Choline salicylate-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Choline salicylate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Choline salicylate-containing product in otic dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Choline salicylate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely choline salicylate 87 milligram/1 gram conventional release oral gel |
Has basis of strength substance (attribute) |
False |
Choline salicylate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely choline salicylate 87 milligram/1 gram conventional release oral gel |
Has precise active ingredient |
False |
Choline salicylate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only choline salicylate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Choline salicylate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Choline salicylate and glycerol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Choline salicylate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Choline salicylate only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Choline salicylate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Choline salicylate only product in otic dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Choline salicylate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely choline salicylate 87 milligram/1 gram conventional release oromucosal gel (clinical drug) |
Has precise active ingredient |
True |
Choline salicylate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely choline salicylate 87 milligram/1 gram conventional release oromucosal gel (clinical drug) |
Has basis of strength substance (attribute) |
True |
Choline salicylate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only choline salicylate in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Choline salicylate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing choline salicylate in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Choline salicylate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cetalkonium chloride 100 microgram/g and choline salicylate 87.14 mg/g oromucosal gel |
Has precise active ingredient |
True |
Choline salicylate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Cetalkonium chloride 100 microgram/g and choline salicylate 87.14 mg/g oromucosal gel |
Has basis of strength substance (attribute) |
True |
Choline salicylate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing cetalkonium and choline salicylate in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Choline salicylate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Cetalkonium and choline salicylate only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Choline salicylate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing cetalkonium and choline salicylate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Choline salicylate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only cetalkonium and choline salicylate in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Choline salicylate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |